Potential COVID-19 Drug Is Successful in Lab Study
A new potential therapy for COVID-19 developed by researchers at Rush University Medical Center has shown success in preventing the disease’s symptoms in mice.
Read more
COVID-19 research
UChicago scientists create first computational model of entire virus responsible for COVID-19
Researchers at the University of Chicago have created the first usable computational model of the entire virus responsible for COVID-19—and they are making this model widely available to help advance research during the pandemic.
Read more
Supercomputers Simulate New Pathways for Potential RNA Virus Treatment
University of New Hampshire (UNH) researchers recently used high-performance supercomputers to identify new inhibitor binding/unbinding pathways in an RNA-based virus. The findings could be beneficial in understanding how these inhibitors react and potentially help develop a new generation of drugs to target viruses with high death rates, such as HIV-1, Zika, Ebola, and SARS-CoV2, the virus that causes COVID-19.
Read moreWoman recovering from COVID-19 shares experience as monoclonal antibody clinical trial participant
When Christina Loville tested positive for the coronavirus, she was terrified. She decided to channel her fear into researching COVID-19 treatments, where she discovered a local clinical trial led by experts at The University of Texas Health Science Center at Houston (UTHealth).
Read more
UC Davis Infectious Disease Expert Available to Comment on COVID-19 following President’s Diagnosis
Dean Blumberg, M.D., is chief of pediatric infectious diseases at UC Davis Children’s Hospital. He has spoken about COVID-19 on
Read more
State funds next steps of Penn State College of Medicine COVID-19 vaccine development
A Penn State College of Medicine research team will continue to work on developing a vaccine for COVID-19 using more than $400,000 in funding from the Pennsylvania Department of Community and Economic Development.
Read moreBlood Test May Point to Patients at Higher Risk for COVID-19 Deterioration, Death
George Washington University researchers found five biomarkers associated with higher odds of clinical deterioration and death in COVID-19 patients. Published in Future Medicine, these findings will help physicians better predict outcomes for COVID-19 patients in the U.S.
Read moreECS Community on the Frontline of COVID-19 Research
In our series, The ECS Community Adapts and Advances, Netzahualcóyotl (Netz) Arroyo-Currás talks about his lab’s challenge as part of the pandemic response of Johns Hopkins Medicine, which is at the forefront of COVID-19 research. Soon after classes went online and labs were shuttered, his team shifted gears to quickly design a COVID-19 diagnostic device to help meet the urgent need to re-open work and study environments.
Read moreTackling COVID-19 with Optimism and Ingenuity
Joe Stetter is an optimist, inventor, entrepreneur, and owner of two small businesses that stayed open through the lockdown. KWJ Engineering and Spec Sensors manufacture essential health and safety sensors with medical and industrial applications. In our series, The ECS Community Adapts and Advances, Joe shares the challenges of doing business “not as usual”, and reports on a research collaboration he mobilized to improve PPE sterilization for COVID-19 frontline workers.
Read moreMemorial Sloan Kettering Awards and Appointments
Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
Read moreLack of lockdown increased COVID-19 deaths in Sweden
Sweden’s controversial decision not to lock down during COVID-19 produced more deaths and greater healthcare demand than seen in countries with earlier, more stringent interventions, a new analysis finds.
Read moreHealth Care Workers at Rush Invited to Participate in National PCORnet Study of Hydroxychloroquine for COVID-19 Preventio
Rush University Medical Center has opened enrollment for a new clinical trial investigating whether the drug hydroxychloroquine is better than a placebo in preventing COVID-19 infection in healthy people working in health care settings.
Read more